Express Scripts To Discuss Outlook for Future Growth
ST. LOUIS, July 25, 2013 /PRNewswire/ — As previously announced, Express Scripts Holding Company (Nasdaq: ESRX) will release its second quarter earnings on Monday, July 29, 2013 after the market closes and will hold its quarterly conference call to discuss second quarter earnings results on Tuesday, July 30, 2013, at 8:30 a.m. Eastern Time (7:30 a.m. Central Time). This call is being webcast and can be accessed from the Investor Information section of Express Scripts’ web site at www.express-scripts.com/corporate
In addition to a discussion of second quarter earnings results and 2013 guidance update, the conference call is expected to include a discussion on drivers of future growth for the industry as well as a discussion of the longer-term growth potential specific to Express Scripts. A slide presentation will accompany the webcast. Following the conference call, both the slide presentation and the webcast will remain available on the Investor Information section of Express Scripts website for 14 days. RealPlayer or Windows Media Player is needed to listen to the webcast and free downloads of these players are available at the webcast site.
About Express Scripts
Express Scripts (NASDAQ: ESRX) manages more than a billion prescriptions each year for tens of millions of patients. On behalf of our clients – employers, health plans, unions and government health programs – we make the use of prescription drugs safer and more affordable. Express Scripts uniquely combines three capabilities – behavioral sciences, clinical specialization and actionable data – to create Health Decision Science(SM), our innovative approach to help individuals make the best drug choices, pharmacy choices and health choices. Better decisions mean healthier outcomes.
Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery, specialty benefit management, benefit-design consultation, drug-utilization review, formulary management, and medical and drug data analysis services. The company also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.
SOURCE Express Scripts